SCHEMBL3845592

SCHEMBL3845592

O=[N+]([O-])c1ccccc1Nc1ccc(Cl)cn1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 1/20 0.61
EPAS1 Q99814 1/20 0.53
MAPK1 P28482 4/20 0.51
L3MBTL1 Q9Y468 3/20 0.51
ALDH1A1 P00352 2/20 0.51
TDP1 Q9NUW8 2/20 0.51
CASP7 P55210 1/20 0.51
MAPT P10636 7/20 0.51
MEN1 O00255 4/20 0.51
KMT2A Q03164 4/20 0.51
PHGDH O43175 1/20 0.49
CGAS Q8N884 1/20 0.48
PKM P14618 2/20 0.48
IDO1 P14902 1/20 0.47
RAB9A P51151 2/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
GAA P10253 1/20 0.47
EGFR P00533 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27168498 0.83 AHR (0.59) AHRMAPK1ALDH1A1MAPTMEN1
SCHEMBL16048112 0.83 AHR (0.59) AHRL3MBTL1ALDH1A1MAPTMEN1
SCHEMBL30777223 0.83 AHR (0.59) AHRMAPK1ALDH1A1MAPTMEN1
SCHEMBL9995235 0.82 KMT2A (0.61) EPAS1MAPK1L3MBTL1ALDH1A1TDP1
SCHEMBL4946668 0.82 KDM4E (0.60) MAPK1L3MBTL1ALDH1A1TDP1CASP7
SCHEMBL30777213 0.80 AHR (0.52) AHRMAPK1L3MBTL1CASP7MAPT
SCHEMBL27168489 0.80 AHR (0.52) AHRMAPK1L3MBTL1CASP7MAPT
SCHEMBL16634682 0.79 HCAR3 (0.58) MAPK1L3MBTL1ALDH1A1TDP1CASP7
SCHEMBL16634686 0.79 HCAR3 (0.58) MAPK1L3MBTL1ALDH1A1TDP1CASP7
SCHEMBL4940849 0.79 MAPT (0.48) MAPK1L3MBTL1ALDH1A1TDP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed